A Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders

Clinical trial NCT06044350 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06044350
Sponsor: Bio-Thera Solutions
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Optic Neuromyelitis Spectrum Disease

Start date: 2023-08-01
Primary completion: 2026-05-31
Enrollment: 162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.